FindTrial
Sign In

Cell-assisted lipotransfer (CAL) after breast-conserving therapy

Cell-assisted lipotransfer (CAL) after breast-conserving therapy - Cell-assisted lipotransfer (CAL) after breast-conserving therapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-C000000458
Enrollment
20
Registered
2006-08-01
Start date
2006-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

deformity after breast-conserving therapy

Interventions

from 1st August, 2006 to 31st July, 2010 injection of adipose tissue and adipose derived (stem) cells single or multiple surgical procedures

Sponsors

Biomaster, Inc.
Lead Sponsor
University of Tokyo University St. Marianna University, School of Medicine
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: healthy person

Exclusion criteria

Exclusion criteria: recurrence of breast cancer

Design outcomes

Primary

MeasureTime frame
volume, chest circumference, safety and efficacy—

Countries

Japan

Contacts

Public ContactKAORU, Okazaki

CELLPORT CLINIC YOKOHAMA CELLPORT CLINIC YOKOHAMA

anesthes@biomaster.jp045-222-3338

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026